60 results
8-K
EX-10.2
FRTX
Fresh Tracks Therapeutics, Inc.
3 May 22
Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals
4:08pm
:
If for BBI: Aron Aizenstat
VP, Corporate Development & Operations
[***]
and
Deepak Chadha
Chief R&D Officer
[***]
If for Botanix: Vince
8-K
EX-99.1
jjso69gb9s0 cst
12 Aug 20
Brickell Biotech Reports Second Quarter 2020 Financial Results
4:05pm
8-K
EX-99.1
2kh7g
13 May 20
Brickell Biotech Reports First Quarter 2020
4:07pm
8-K/A
EX-99.1
skyz 5014pzqy7envu6k
10 Feb 20
Index to Financial Statements
4:51pm
8-K
EX-99.1
bvllm
13 Nov 19
Brickell Bio Announces Third Quarter 2019
4:10pm
8-K
EX-99.1
fmlo 84u9e3
30 Oct 19
Brickell Biotech Provides Update on Bodor Labs Complaint and Funding Agreement with NovaQuest
4:44pm
8-K
EX-99.3
fikaa
3 Sep 19
Brickell Biotech Completes Merger with Vical
7:02am
8-K
EX-99.1
e2o d9n9p
3 Sep 19
Brickell Biotech Completes Merger with Vical
7:02am